EMB News Today: Stay Updated with the Latest iShares J.P. Morgan USD Emerging Markets Bond ETF News in Real Time
Find EMB news now at Meyka AI. Stay informed with the latest iShares J.P. Morgan USD Emerging Markets Bond ETF stocks updates, including price news, market analysis, and expert insights.
Fujikura Stock Shows Buying Interest on June 16
Fujikura stock shows buying interest amid Tokyo market rally on US-Iran peace deal. Japanese cable manufacturer trades on Tokyo Stock Exchange.
BYD Expands EV Lineup as Sodium Battery Strategy Takes Shape, June 15
BYD launches Denza N8L and Sealion 08 EVs while developing low-cost sodium batteries for energy storage applications.
Telefónica Offers 9.15% Dividend Yield as European Telecom Sector Stabilizes
Telefónica stock offers 9.15% dividend yield with $21.84B market cap. Recent dividend of $0.17 paid Dec 2025. 52-week range $3.81-$5.71.
US Economy Outpaces Global Peers Despite Trade Tariffs, June 15
US economy grows 2% annually with 13.9% capital spending and energy independence, driving resilience despite tariffs and global shocks.
Oil Prices Plunge 4.5% as US-Iran Peace Deal Reopens Strait of Hormuz, June 15
US-Iran peace deal announced June 14 triggers oil price collapse to $82.84. Strait of Hormuz reopens June 19, ending energy crisis.
Gold Surges Past $4,300 on US-Iran Peace Deal, June 16
Gold rebounds to $4,335 USD following US-Iran peace deal announcement, recovering from 6-month lows as Hormuz Strait reopens.
CBP Orders 200 Sentry Towers From Anduril for $363 Million, June 15
CBP purchases 200+ Extended Range Sentry Towers from Anduril for $363M to expand autonomous border surveillance capabilities.
ASX 200 Surges 1.3% on US-Iran Peace Deal, June 15
ASX 200 rises 110 points to 8,914 on Iran peace deal. Oil falls 4.3%, gold rises 2.2%. BHP hits record high amid sector rotation.
Traws Pharma Stock Drops 17% After UK Regulator Delays Flu Drug Trial
One regulatory hold is a setback. Two is a pattern, and Traws Pharma is now facing exactly that. On June 12, 2026, Traws Pharma (NASDAQ: TRAW) announced that its planned Phase 2a human influenza challenge study of tivoxavir marboxil (TXM) has been deferred following a negative review by the UK’s Medicines and Healthcare Products Regulatory…